Inozyme Pharma, Inc. (INZY) Depreciation USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Inozyme Pharma, Inc. annual Depreciation history and growth rate from 2020 to 2023.
  • Inozyme Pharma, Inc. annual Depreciation for 2023 was $833 K, a 12% increase from 2022.
  • Inozyme Pharma, Inc. annual Depreciation for 2022 was $744 K, a 10.4% increase from 2021.
  • Inozyme Pharma, Inc. annual Depreciation for 2021 was $674 K, a 211% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $833 K +$89 K +12% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $744 K +$70 K +10.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $674 K +$457 K +211% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $217 K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.